Previous Article | Next Article 
Journal of Clinical Microbiology, September 2007, p. 2798-2801, Vol. 45, No. 9
0095-1137/07/$08.00+0 doi:10.1128/JCM.02486-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Convenient Test Using a Combination of Chelating Agents for Detection of Metallo-ß-Lactamases in the Clinical Laboratory
Soo-Young Kim,
Seong Geun Hong,
Ellen S. Moland, and
Kenneth S. Thomson*
Center for Research in Anti-Infectives and Biotechnology, Department of Medical Microbiology & Immunology, Creighton University School of Medicine, 2500 California Plaza, Omaha, Nebraska 68178
Received 12 December 2006/
Returned for modification 14 March 2007/
Accepted 18 June 2007

ABSTRACT
Although transmissible metallo-ß-lactamases (MBLs)
are a serious threat to ß-lactam antibiotic therapy,
the CLSI currently does not recommend testing methods for the
detection of MBLs. The aim of this study was to evaluate the
capability of double-disk tests (DDTs) by using disks containing
a combination of the chelators 2-mercaptopropionic acid (MPA)
and Tris-EDTA (TE) to detect MBLs. Sixteen isolates (4
Acinetobacter baumannii isolates, 6
Pseudomonas aeruginosa isolates, 1
Serratia marcescens isolate, 1
Aeromonas hydrophila isolate, 1
Aeromonas veronii isolate, 2
Chryseobacterium meningosepticum isolates,
and 1
Stenotrophomonas maltophilia isolate) producing IMP-1,
IMP-1-like, IMP-18, GIM-1, SPM-1, VIM-2, VIM-2-like, and chromosomal
MBLs and 20 isolates (7
Klebsiella pneumoniae isolates, 3
Escherichia coli isolates, 5
Enterobacter cloacae isolates, 2
S. marcescens isolates, 1
Proteus mirabilis isolate, and 2
A. baumannii isolates)
producing non-MBL carbapenemases, AmpC ß-lactamases,
and extended-spectrum ß-lactamases were tested. The
DDT method was evaluated by using four types of chelator disks
(TE, high-strength TE, MPA, and TE plus 20 µl of MPA [at
various concentrations]) and the ß-lactams imipenem
(IPM), meropenem (MEM), ertapenem (ERT), and ceftazidime (CAZ).
DDTs with IPM and a TE disk supplemented with 1:320 MPA detected
all MBLs and yielded no false-positive results. Some, but not
all, MBL producers were detected in IPM-based tests involving
the single chelator TE or MPA alone or by ERT- or CAZ-based
tests. IPM-based tests with MPA concentrations other than 1:320
and all MEM-based tests had suboptimal sensitivities or specificities.
DDT with IPM and a TE disk supplemented with 20 µl of
1:320 MPA appears to be convenient for the detection of MBLs
in the clinical laboratory.

INTRODUCTION
Carbapenems are the drugs of choice for the treatment of infections
caused by multiresistant gram-negative bacilli. Carbapenemases
involved in acquired resistance are of Ambler molecular classes
A, B, and D (
4). The class B enzymes, metallo-ß-lactamases
(MBLs), are the most clinically threatening carbapenemases,
because they are capable of hydrolyzing all ß-lactams
except aztreonam. Gram-negative bacilli producing acquired MBLs
have been reported in many countries and are sometimes carbapenem
susceptible in vitro under standard conditions, making them
difficult to recognize (
4,
7). Therefore, accurate detection
is important for optimal therapy and infection control precautions.
Recently, an E-test MBL strip (AB Biodisk, Solna, Sweden) was
recommended for use for screening for MBLs in clinical laboratories,
but it has been reported to be unable to detect all MBL-positive
members of the family
Enterobacteriaceae and also to give false-positive
results with some
Pseudomonas aeruginosa and
Acinetobacter baumannii strains (
5,
7). Although various MBL detection techniques have
been investigated, there are currently no perfect phenotypic
methods for the detection of all transferable MBLs (
7).
Here we report on a study performed to evaluate the utility of double-disk tests (DDTs) involving disks containing imipenem (IPM), meropenem (MEM), ertapenem, (ERT), and ceftazidime (CAZ); disks containing low and high concentrations of Tris-EDTA (TE); disks containing 2-mercaptopropionic acid (MPA); and TE disks supplemented with MPA for the detection of MBL producers.

MATERIALS AND METHODS
Bacterial strains.
Sixteen isolates (4
A. baumannii isolates, 6
P. aeruginosa isolates,
1
Serratia marcescens isolate, 1
Aeromonas hydrophila isolate,
1
Aeromonas veronii isolate, 2
Chryseobacterium meningosepticum isolates, and 1
Stenotrophomonas maltophilia isolate) producing
IMP-1, IMP-1-like, IMP-18, GIM-1, SPM-1, VIM-2, VIM-2-like,
and chromosomal MBLs and 20 isolates (7
Klebsiella pneumoniae isolates, 3
Escherichia coli isolates, 5
Enterobacter cloacae isolates, 2
S. marcescens isolates, 1
Proteus mirabilis isolate,
and 2
A. baumannii isolates) producing class A and D carbapenemases
(IMI-1, KPC-2, KPC-3, NMC-A, SME-like, and OXA-23), AmpC ß-lactamases,
and extended-spectrum ß-lactamases (ESBLs) were studied
(Table
1).
Detection of MBLs.
Four types of disks containing chelating agents were investigated.
These were (i) TE disks (BD Diagnostic Systems, Sparks, MD)
premoistened with 20 µl saline; (ii) TE disks supplemented
with 20 µl of 1:80, 1:160, 1:320, 1:640, and 1:1,280 dilutions
of MPA (T31003-5G; Sigma-Aldrich Corp., St. Louis, MO); (iii)
high-strength TE disks, i.e., TE disks supplemented with 20
µl of either undiluted TE or a 1:16 dilution of 100
x TE
(T-9285; Sigma-Aldrich Corp.); and (iv) MPA disks, i.e., blank
disks supplemented with 20 µl of a 1:80 or 1:320 dilution
of MPA. The test strains were adjusted to a McFarland 0.5 standard
and inoculated as lawns onto Mueller-Hinton agar plates (Oxoid
Ltd., Basingstoke, England). Disks containing 10 µg IPM,
MEM, or ERT or 30 µg CAZ (BD Diagnostic Systems) were
placed on the surface, and the chelator disk was placed 10 mm
(edge to edge) from the ß-lactam disk. After incubation
overnight at 37°C, any clear extension of the inhibition
zone around the carbapenem disk toward the TE disk was interpreted
as a positive result.

RESULTS
As shown in Table
1, the IPM-based test with a TE disk supplemented
with 1:320 MPA provided the most sensitive (100%) and specific
(100%) test for MBL detection. In tests with IPM, the unsupplemented
or high-strength TE disks did not detect IMP-1 in two isolates
of
A. baumannii (Fig.
1) and SPM-1 in one isolate of
P. aeruginosa.
MPA disks alone failed to detect a VIM-2-like MBL in one isolate
of
P. aeruginosa (Fig.
2A). Three of the five chromosomal MBL-producing
isolates (two
C. meningosepticum isolates and one
S. maltophilia isolate) yielded strongly positive results with IPM and a TE
disk supplemented with 1:320 MPA, but two isolates (one
A. hydrophila isolate and one
A. veronii isolate) yielded only weakly positive
results. Higher MPA concentrations (1:80 and 1:160) were associated
with false-positive results in tests with IPM and some class
A carbapenemase-, AmpC-, and ESBL-producing isolates; and lower
MPA concentrations (1:640 and 1:1,280) reduced the sensitivity
of the test. MEM-based tests with lower MPA concentrations (1:320
to 1:1,280) had suboptimal sensitivities (63.6 to 81.8%), while
those with higher MPA concentrations (1:80 to 1:320) had suboptimal
specificities (50 to 75%) (Table
1 and Fig.
3). ERT-based tests
were too insensitive (54.5%) with the highest MPA concentration
(1:80). CAZ-based tests exhibited larger inhibition zones in
tests with five
P. aeruginosa isolates, including one VIM-2-like
MBL-producing
P. aeruginosa isolate, than the corresponding
IPM-based tests (Fig.
2), but were less sensitive because they
failed to detect one IMP-1-producing
A. baumannii isolate (Fig.
1).

DISCUSSION
It is necessary to perform MBL detection tests with suspicious
isolates because these enzymes cannot be identified by routine
susceptibility tests. Suspicious isolates are those with significantly
reduced susceptibility to carbapenems, e.g.,
E. coli and
Klebsiella isolates with imipenem MICs of 1 µg/ml or higher;
Enterobacter,
Citrobacter freundii, and
S. marcescens isolates with imipenem
MICs of 4 µg/ml or higher; and
P. aeruginosa isolates
with imipenem MICs of 8 µg/ml or higher. Tests involving
chelating agents such as EDTA and MPA are useful because the
chelators are specific inhibitors of MBLs but not of other ß-lactamases
(
1-
3,
5-
8). A single chelating agent may sometimes not adequately
inhibit all MBLs in certain pathogens, making it necessary to
use a mixture of chelating agents for the reliable detection
of MBLs.
The IPM-based test involving TE alone did not detect two IMP-1-producing A. baumannii isolates (Fig. 1) and one SPM-1-producing P. aeruginosa isolate, whereas The IPM-based test involving MPA alone failed to detect one VIM-2-like MBL-producing P. aeruginosa isolate. Positive tests with these isolates were obtained only when an MPA-supplemented TE disk was used. The finding that two chelators were needed was consistent with the findings presented in the report of Lee et al. (3) that EDTA disks were more sensitive than sodium mercaptoacetic acid (SMA) disks for the detection of MBL-producing pseudomonads, while SMA disks provided more sensitive tests for the detection of MBL-producing acinetobacters. The MPA concentration used for supplementation of the TE disks was critical, with a 1:320 dilution providing optimal specificity and sensitivity.
The tests with the MEM, ERT, and CAZ disks yielded some inaccurate results and were less satisfactory than the tests with IPM disks. Arakawa et al. (1) reported that CAZ disks used in conjunction with MPA provided optimal MBL detection because MBL producers were usually highly resistant to CAZ (MIC, >64 µg/ml). However, Lee et al. (3) reported that MBL production by some Acinetobacter isolates was difficult to detect by tests based on CAZ disks and attributed this to the possibility that the isolates may have additional CAZ resistance mechanisms, such as ESBL and AmpC production. In our study, the MBL activity of one Acinetobacter isolate was not detected with the CAZ disk, although this isolate was highly resistant to CAZ (MIC, >64 µg/ml).
Our findings with 16 MBL-producing isolates that produced IMP-1, IMP-1-like, IMP-18, GIM-1, SPM-1, VIM-2, VIM-2-like, and chromosomal MBLs suggest that a convenient and accurate screening method suitable for use in clinical laboratories for the detection of MBL producers may be provided by use of the IPM and TE disk supplemented with 20 µl of 1:320 MPA. Because only a modest number of isolates that produced MBLs were included in this study, it is necessary for further evaluation of this method to be undertaken.

ACKNOWLEDGMENTS
We thank the following microbiologists for isolates used in
this study: K. Lee, Yonsei University College of Medicine, Seoul,
Korea; M. Inoue, Kitasato University School of Medicine, Sagamihara,
Japan; and L. M. Deshpande, JMI Laboratories, North Liberty,
IA.

FOOTNOTES
* Corresponding author. Mailing address: Center for Research in Anti-Infectives and Biotechnology, Department of Medical Microbiology & Immunology, Creighton University School of Medicine, 2500 California Plaza, Omaha, NE 68178. Phone: (402) 280-1881. Fax: (402) 280-1225. E-mail:
kstaac{at}creighton.edu 
Published ahead of print on 27 June 2007. 

REFERENCES
1 - Arakawa, Y., N. Shibata, K. Shibayama, H. Kurokawa, T. Yagi, H. Fujiwara, and M. Goto. 2000. Convenient test for screening metallo-ß-lactamase-producing gram-negative bacteria by using thiol compounds. J. Clin. Microbiol. 38:40-43.[Abstract/Free Full Text]
2 - Lee, K., Y. Chong, H. B. Shin, Y. A. Kim, D. Yong, and J. H. Yum. 2001. Modified Hodge and EDTA-disk synergy tests to screen metallo-ß-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin. Microbiol. Infect. 7:88-91.[CrossRef][Medline]
3 - Lee, K., Y. S. Lim, D. Yong, J. H. Yum, and Y. Chong. 2003. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-ß-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 41:4623-4629.[Abstract/Free Full Text]
4 - Nordmann, P., and L. Poirel. 2002. Emerging carbapenemases in gram-negative aerobes. Clin. Microbiol. Infect. 8:321-331.[CrossRef][Medline]
5 - Segal, H., and B. G. Elisha. 2005. Use of Etest MBL strips for the detection of carbapenemases in Acinetobacter baumannii. J. Antimicrob. Chemother. 56:598.[Free Full Text]
6 - Walsh, T. R., A. Bolmstrom, A. Qwarnstrom, and A. Gales. 2002. Evaluation of a new Etest for detecting metallo-ß-lactamases in routine clinical testing. J. Clin. Microbiol. 40:2755-2759.[Abstract/Free Full Text]
7 - Walsh, T. R., M. A. Toleman, L. Poirel, and P. Nordmann. 2005. Metallo-ß-slactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.[Abstract/Free Full Text]
8 - Yong, D., K. Lee, J. H. Yum, H. B. Shin, G. M. Rossolini, and Y. Chong. 2002. Imipenem-EDTA disk method for differentiation of metallo-ß-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 40:3798-3801.[Abstract/Free Full Text]
Journal of Clinical Microbiology, September 2007, p. 2798-2801, Vol. 45, No. 9
0095-1137/07/$08.00+0 doi:10.1128/JCM.02486-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Peleg, A. Y., Seifert, H., Paterson, D. L.
(2008). Acinetobacter baumannii: Emergence of a Successful Pathogen. Clin. Microbiol. Rev.
21: 538-582
[Abstract]
[Full Text]